Keyword: Boston Children's Hospital
The latest biotech discoveries include a role for CDK inhibition in bone cancer and a gene involved in heart defects.
Scientists at Boston Children’s Hospital are developing a PD-L1-boosting therapy to curb the wayward autoimmune reaction that causes Type 1 diabetes.
Researchers at Boston Children’s Hospital have discovered an approach that could suppress a tumor’s growth by altering its metabolism.
Researchers have used data gathered by connected thermometers to predict the onset of an influenza outbreak.
A team from the Carnegie Institution for Science has visualized, for the first time, how fats are metabolized in zebrafish.
Harvard professor Timothy Springer spoke to FierceBiotechResearch about the new Institute for Protein Innovation, which he created to further the development of antibodies targeting proteins that reside outside of cell walls.
NFANT Labs, Boston Children’s Hospital and Harvard Medical School are joining forces to investigate a link between feeding performance and neonatal brain injury.
Scientists at Harvard Medical School are reporting today that they’ve perfected a form of gene therapy originally developed to restore hearing, and as a result, genetically deaf mice are able to hear down to 25 decibels. That’s the equivalent of a whisper.
GE Healthcare is teaming up with Boston Children’s Hospital to develop digital tools for the diagnosis and treatment of childhood diseases with an initial focus on diagnostic imaging for brain disease.